Date: 2016-02-03
Type of information: Opening of new premises
Compound:
Company: Quantum Genomics (France)
Therapeutic area: Cardiovascular diseases
Type agreement: opening of new premises
Action mechanism:
Disease:
Details: * On February 3, 2016, Quantum Genomics announced its intention to establish a new office in New York City to
advance its clinical programs and expand its presence in the United States. The launch of this New York office is expected to help strengthen Quantum Genomics’ development activities in the U.S. and enable the Company to more effectively engage with members of the U.S. medical and investment communities.
Financial terms:
Latest news:
